Buenos Aires, Argentina

Luis Baraldo

USPTO Granted Patents = 4 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2011-2017

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Luis Baraldo in Photolabile Compounds

Introduction

Luis Baraldo is an accomplished inventor based in Buenos Aires, Argentina. He has made significant contributions to the field of photolabile compounds, holding a total of four patents. His work focuses on the development of compounds that can be activated by light, which has important implications for biological applications.

Latest Patents

One of Luis Baraldo's latest patents involves photolabile compounds that feature a photoreleasable ligand. This ligand can be biologically active and is released from the compound upon exposure to light. In some embodiments, the compounds include a light antenna, such as a labeling molecule or an active derivative thereof. Notably, the light used can be visible light, which does not harm the viability of biological samples, such as cells and tissues. The released organic molecule can be bioactive and may have therapeutic effects. Additionally, the photoreleasable ligand can serve as a labeling molecule, including fluorescent molecules.

Career Highlights

Luis Baraldo has worked with prestigious institutions such as Columbia University and Universidad de Buenos Aires. His experience in these organizations has allowed him to collaborate with leading experts in the field and further his research in innovative compounds.

Collaborations

Luis has collaborated with notable individuals, including Roberto Etchenique and Rafael Yuste. These partnerships have contributed to the advancement of his research and the development of his patented technologies.

Conclusion

Luis Baraldo's work in photolabile compounds showcases his innovative spirit and dedication to advancing scientific knowledge. His contributions have the potential to impact various fields, particularly in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…